Inj, pemivibart, 4500 mg
Full descriptor
Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
Details
- Code
- Q0224
- Short descriptor
- Inj, pemivibart, 4500 mg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Mar 22 2024
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj, tocilizumab-bavi, 1mg
Inj, monoclon antibody, 1 mg
Inj, tocilizumab-anoh, hospi
Inj, tocilizumab-aazg, hospi
Tocilizumab for covid-19
Unspecified oral anti-emetic
Dolasetron mesylate oral
Hydroxyzine pamoate 25mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.